Loading clinical trials...

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT03184324

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

The purpose of this study is to determine the efficacy and safety of DWP14012 compared to esomeprazole in the treatment of erosive gastroesophageal reflux disease classified as Los Angeles(LA) classif...

Lead sponsor: Daewoong Pharmaceutical Co. LTD.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

Not Yet Recruiting

JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

NCT07115706 · Erosive Gastroesophageal Reflux Disease

Not Yet RecruitingPhase 1

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

NCT06437951 · Erosive Gastroesophageal Reflux Disease

UNKNOWNPhase 3

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease

NCT03811080 · Non-Erosive Gastroesophageal Reflux Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 3, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment211

Start dateAug 2017

Last updatedSep 3, 2020

Condition

Erosive Gastroesophageal Reflux Disease

Locations shown

Hanyang University Medical Center

Sungdong-gu, Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 3, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions